CRISPR Therapeutics
CRISPR Therapeutics is an investor based in the United States, investing in Healthcare & Life Sciences, Pharmaceutical Development and Genomics & Molecular Biology, 2 tracked investments.
About CRISPR Therapeutics
CRISPR Therapeutics is an investor headquartered in the United States. We have recorded 2 investments for CRISPR Therapeutics to date.
Sector activity concentrates in Healthcare & Life Sciences, Pharmaceutical Development, Genomics & Molecular Biology and Chronic Care Management. Coverage extends to 8 sectors in total. Investments are concentrated at Series C+.
CRISPR Therapeutics is focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. The company is applying this technology platform to research, develop and commercialize medicines for various diseases.
Investment Focus
Explore CRISPR Therapeutics's full profile on Brouky
Portfolio companies, co-investors, AI match scores, and deal flow signals.
Other Investors in United States
Crinetics Pharmaceuticals
Healthcare & Life Sciences, biotechnology, oncology
CRH Ventures
Energy, Environment & Mobility, Circular Economy, Sustainability
Crew Capital
Software & Developer Tools, AI, smb-services
CRE Venture Capital
Commerce & Marketing, Energy, Environment & Mobility, Finance & Blockchain
Crocker Ventures
Software & Developer Tools, Lab as a Service, Medical Diagnostics
Croghan Investments
Finance & Blockchain, Consumer Fintech, Personal Finance & Wellness
Crosscourt Ventures
Software & Developer Tools, Cybersecurity, threat-detection
CrossCreek Capital
Software & Developer Tools, Finance & Blockchain, Commerce & Marketing